CLINICAL AND PARACLINICAL CHARACTERISTICS IN NASOPHARYNGEAL CANCER PATIENTS

Huy Tần Phạm, Thế Ngọc Dương

Main Article Content

Abstract

Objectives: To investigate the clinical and paraclinical characteristics of nasopharyngeal cancer patients at Hanoi Medical University Hospital and K Hospital. Subjects: A total of 119 patients diagnosed and treated for nasopharyngeal cancer at K Hospital and the Center for Gene and Protein Research - Hanoi Medical University, Hanoi Medical University Hospital. Methods: Cross-sectional study. Results: The most common clinical symptoms of nasopharyngeal cancer were headache (56.3%) and tinnitus (55.5%). Cranial nerve damage was observed in 15.1% of patients. Most lesions identified by endoscopy were exophytic tumors (86.5%), primarily originating from the Rosenmüller fossa (72.3%) and the superior posterior wall (50.4%). Tumor invasion was detected by MRI/CT in 74.8% of patients, with 87.6% of these cases showing extension into the nasal cavity and sinuses. Regarding cervical lymph nodes, 74.8% of patients presented with lymphadenopathy, predominantly involving the high jugular lymph node group (95.5%). Most patients had 1-2 cervical nodes (69.6%), typically unilateral (56.2%). Metastasis was found in 58.4% of cases. TNM classification indicated that most patients were in advanced stages (T3-T4: 44.5%; N1-N3: 74.8%), while 98.3% had no distant metastasis (M0). Conclusion: This study highlights the importance of early recognition of nasopharyngeal cancer characteristics to enhance diagnostic efficacy. The findings provide a scientific basis for improving early detection and treatment strategies for this condition in clinical practice.

Article Details

References

Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians. 2024;74(1): 12-49. doi:10.3322/caac. 21820
2. Cancer Today. Accessed December 29, 2024. https://gco.iarc.who.int/today/
3. Dee EC, Eala MA, Feliciano EJG, et al. Nasopharynx Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality. International Journal of Radiation Oncology, Biology, Physics. 2024;120(2):e746-e747. doi:10. 1016/j.ijrobp.2024.07.1640
4. Hsu CL, Chang YS, Li HP. Molecular Diagnosis of Nasopharyngeal Carcinoma: Past and Future. Biomedical Journal. Published online May 23, 2024:100748. doi:10.1016/j.bj.2024.100748
5. Nguyễn Xuân Hùng, Phạm Nguyên Tường, Đặng Thanh. Nghiên cứu kết quả điều trị ung thư vòm mũi họng bằng hóa xạ trị đồng thời tại Bệnh viện Trung ương Huế. Tạp chí Tai Mũi Họng Việt Nam. 2015;60(25):37-43.
6. Tyagi RK, Parmar R, Patel N. A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma. Hum Vaccin Immunother. 2017;13(4): 854-866. doi:10.1080/21645515.2016.1256518
7. Lê Văn Quảng, Nguyễn Văn Tuyền. Đặc điểm lâm sàng, cận lâm sàng bệnh ung thư vòm mũi họng giai đoạn I-II. Tạp chí Y học thực hành. 2014;924(7):71-74.
8. Iseh KR, Abdullahi A, Malami SA. Clinical and histological characteristics of nasopharyngeal cancer in Sokoto, north-western, Nigeria. West Afr J Med. 2009;28(3):151-155. doi:10.4314/ wajm.v28i3.48438
9. Lee VHF, Kwong DLW, Leung TW, et al. Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma. Oncotarget. 2017; 8(3):5292-5308. doi:10.18632/oncotarget. 14137